CL2020000097A1 - Polypeptide molecule with enhanced dual specificity. - Google Patents
Polypeptide molecule with enhanced dual specificity.Info
- Publication number
- CL2020000097A1 CL2020000097A1 CL2020000097A CL2020000097A CL2020000097A1 CL 2020000097 A1 CL2020000097 A1 CL 2020000097A1 CL 2020000097 A CL2020000097 A CL 2020000097A CL 2020000097 A CL2020000097 A CL 2020000097A CL 2020000097 A1 CL2020000097 A1 CL 2020000097A1
- Authority
- CL
- Chile
- Prior art keywords
- lymphocyte
- specific
- cells
- polypeptide molecule
- union
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA MOLÉCULA DE POLIPÉPTIDO BIESPECÍFICA QUE COMPRENDE UNA PRIMERA CADENA POLIPEPTÍDICA Y UNA SEGUNDA CADENA POLIPEPTÍDICA QUE PROPORCIONA UNA REGIÓN DE UNIÓN DERIVADA DE UN RECEPTOR DE LINFOCITO T (TCR) QUE ES ESPECÍFICA PARA UN EPÍTOPO PEPTÍDICO VÍRICO ASOCIADO AL COMPLEJO PRINCIPAL DE HISTOCOMPATIBILIDAD (MHC), Y UNA REGIÓN DE UNIÓN DERIVADA DE UN ANTICUERPO CAPAZ DE RECLUTAR CÉLULAS EFECTORAS INMUNITARIAS HUMANAS MEDIANTE LA UNIÓN ESPECÍFICA A UN ANTÍGENO DE SUPERFICIE DE DICHAS CÉLULAS, ASÍ COMO MÉTODOS PARA FABRICAR LA MOLÉCULA DE POLIPÉPTIDO BIESPECÍFICA, Y USOS DE LA MISMA.THE PRESENT INVENTION REFERS TO A BI-SPECIFIC POLYPEPTIDE MOLECULE THAT COMPRISES A FIRST POLYPEPTIDE CHAIN AND A SECOND POLYPEPTIDE CHAIN THAT PROVIDES A BINDING REGION DERIVED FROM A LYMPHOCYTE RECEPTOR FOR UNIQUE TYPICAL EPYPHYPHIC TCRYPE LYMPHOCYTE (TCR) WHICH IS SPECIFIC TO THE LYMPHOCYTE LYMPHOCYTE RECEPTOR PRINCIPLE VEPÍTICO VEPÍFICO VEPÍTÍGOS OF HISTOCOMPATIBILITY (MHC), AND A REGION OF UNION DERIVED FROM AN ANTIBODY CAPABLE OF RECRUITING HUMAN IMMUNE EFFECTIVE CELLS THROUGH THE SPECIFIC UNION TO A SURFACE ANTIGEN OF SAID USED CELLS, AS WELL AS MULTIPLE POLYTICAL, USED MELOSPYPETIC CELLS SAME.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762532713P | 2017-07-14 | 2017-07-14 | |
DE102017115966.5A DE102017115966A1 (en) | 2017-07-14 | 2017-07-14 | Polypeptide molecule with improved dual specificity |
DE102017119866 | 2017-08-30 | ||
US201862658318P | 2018-04-16 | 2018-04-16 | |
DE102018108995 | 2018-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2020000097A1 true CL2020000097A1 (en) | 2020-05-29 |
Family
ID=70848164
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2020000098A CL2020000098A1 (en) | 2017-07-14 | 2020-01-13 | Polypeptide molecule with enhanced dual specificity. |
CL2020000097A CL2020000097A1 (en) | 2017-07-14 | 2020-01-13 | Polypeptide molecule with enhanced dual specificity. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2020000098A CL2020000098A1 (en) | 2017-07-14 | 2020-01-13 | Polypeptide molecule with enhanced dual specificity. |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2021019626A (en) |
CL (2) | CL2020000098A1 (en) |
HR (1) | HRP20210759T1 (en) |
IL (2) | IL272046A (en) |
PH (2) | PH12020500098A1 (en) |
ZA (1) | ZA202000636B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014244286B2 (en) * | 2013-03-14 | 2018-11-08 | Duke University | Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor |
-
2020
- 2020-01-13 CL CL2020000098A patent/CL2020000098A1/en unknown
- 2020-01-13 CL CL2020000097A patent/CL2020000097A1/en unknown
- 2020-01-14 PH PH12020500098A patent/PH12020500098A1/en unknown
- 2020-01-14 IL IL272046A patent/IL272046A/en unknown
- 2020-01-14 IL IL272045A patent/IL272045A/en unknown
- 2020-01-14 PH PH12020500095A patent/PH12020500095A1/en unknown
- 2020-01-30 ZA ZA2020/00636A patent/ZA202000636B/en unknown
- 2020-10-23 JP JP2020177784A patent/JP2021019626A/en active Pending
-
2021
- 2021-05-12 HR HRP20210759TT patent/HRP20210759T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12020500095A1 (en) | 2020-12-07 |
ZA202000636B (en) | 2021-07-28 |
CL2020000098A1 (en) | 2020-05-29 |
JP2021019626A (en) | 2021-02-18 |
IL272046A (en) | 2020-03-31 |
HRP20210759T1 (en) | 2021-06-11 |
IL272045A (en) | 2020-03-31 |
PH12020500098A1 (en) | 2020-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020001491A2 (en) | Polypeptide molecule with enhanced dual specificity | |
CY1121962T1 (en) | T CELL RECEPTORS | |
AR110676A1 (en) | TREATMENT OF CANCER USING CHEMERIC ANTIGENS RECEPTORS | |
CL2018000461A1 (en) | Bispecific antibodies with tetravalence for a co-stimulator fnt receptor. | |
CO2018001405A2 (en) | Chimeric antigen receptor based on single domain antibodies | |
AR105433A1 (en) | METHODS TO IMPROVE THE EFFECTIVENESS AND EXPANSION OF IMMUNE CELLS | |
MX2023006482A (en) | Bispecific antibodies specific for a costimulatory tnf receptor. | |
GT201700162A (en) | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123 | |
EA201792467A1 (en) | HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | |
BR112018067458A2 (en) | antibodies to tigit | |
CO2017006808A2 (en) | Bcma chimeric antigen receptors | |
BR112018014760A2 (en) | anti-ror1 antibodies, bispecific antibodies to ror1 x cd3 and methods of use | |
EA201791139A1 (en) | HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | |
AR104718A1 (en) | RECEIVERS OF ANTI-GD3 SPECIFIC CHEMICAL ANTIGENS FOR IMMUNOTHERAPIES AGAINST CANCER | |
CO7111273A2 (en) | CD47 antibodies and methods of use thereof | |
CO2019013654A2 (en) | Chimeric antigen receptors targeting flt3 | |
CL2018003515A1 (en) | Anti-gitr antibodies and their uses. | |
GT201300233A (en) | RECEIVERS OF SIMILAR T-CELLS TO SPECIFIC ANTIBODIES FOR A WT1 PEPTIDE PRESENTED BY HLA-A2 | |
BR112017015287A2 (en) | antibodies to fcrn and methods of using them | |
AR115052A1 (en) | MULTI-SPECIFIC ANTIBODIES AND THE USE OF THEM | |
BR112022024228A2 (en) | CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS | |
CO2018012497A2 (en) | Interferon beta antibodies and uses thereof | |
CO2020014343A2 (en) | Cd3-specific antibodies and their uses | |
CO2019003759A2 (en) | Antibodies that bind to the zika virus envelope protein and uses thereof | |
AR112228A1 (en) | POLYPEPTIDE MOLECULE WITH ENHANCED DUAL SPECIFICITY |